» Articles » PMID: 1303231

Peripheral Myelin Protein-22 Gene Maps in the Duplication in Chromosome 17p11.2 Associated with Charcot-Marie-Tooth 1A

Overview
Journal Nat Genet
Specialty Genetics
Date 1992 Jun 1
PMID 1303231
Citations 72
Authors
Affiliations
Soon will be listed here.
Abstract

Charcot-Marie-Tooth disease 1A (CMT1A) is a hereditary demyelinating peripheral neuropathy, associated with a DNA duplication on chromosome 17p11.2. A related disorder in the mouse, trembler (Tr), maps to mouse chromosome 11 which has syntenic homology to human chromosome 17p. Recently, the peripheral myelin protein-22 (pmp-22) gene was identified as the likely Tr locus. We have constructed a partial yeast artificial chromosome contig spanning the CMT1A gene region and mapped the PMP-22 gene to the duplicated region. These observations further implicate PMP-22 as a candidate gene for CMT1A, and suggest that over-expression of this gene may be one mechanism that produces the CMT1A phenotype.

Citing Articles

Genetics of inherited peripheral neuropathies and the next frontier: looking backwards to progress forwards.

Parmar J, Laing N, Kennerson M, Ravenscroft G J Neurol Neurosurg Psychiatry. 2024; 95(11):992-1001.

PMID: 38744462 PMC: 11503175. DOI: 10.1136/jnnp-2024-333436.


A study concept of expeditious clinical enrollment for genetic modifier studies in Charcot-Marie-Tooth neuropathy 1A.

Xu I, Danzi M, Ruiz A, Raposo J, Arcia de Jesus Y, Reilly M J Peripher Nerv Syst. 2024; 29(2):202-212.

PMID: 38581130 PMC: 11209807. DOI: 10.1111/jns.12621.


The First Large Deletion of Identified in a Patient Presenting with a Sensory Polyneuropathy.

Pyromali I, Richard L, Derouault P, Vallat J, Ghorab K, Magdelaine C Biomedicines. 2023; 11(6).

PMID: 37371660 PMC: 10295399. DOI: 10.3390/biomedicines11061565.


Current Advances in Gene Therapies of Genetic Auditory Neuropathy Spectrum Disorder.

Saidia A, Ruel J, Bahloul A, Chaix B, Venail F, Wang J J Clin Med. 2023; 12(3).

PMID: 36769387 PMC: 9918155. DOI: 10.3390/jcm12030738.


A translatable RNAi-driven gene therapy silences PMP22/Pmp22 genes and improves neuropathy in CMT1A mice.

Stavrou M, Kagiava A, Choudury S, Jennings M, Wallace L, Fowler A J Clin Invest. 2022; 132(13).

PMID: 35579942 PMC: 9246392. DOI: 10.1172/JCI159814.